Home News & Events ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development Read the press release ICON expands US early phase research capabilities with new clinic and outpatient centres Read the press release ICON and Advarra introduce new ‘research-ready,’ connected site network model Read the press release Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Press releases 31 July 2026 ICON announces results of Annual General Meeting 29 July 2026 ICON reports second quarter 2026 results 28 July 2026 ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials 22 July 2026 ICON schedules second quarter 2026 earnings conference call 23 June 2026 ICON reports first quarter 2026 results 22 June 2026 ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development 18 June 2026 ICON schedules first quarter 2026 earnings conference call 28 May 2026 ICON reports fourth quarter and full year 2025 results 13 May 2026 ICON expands US early phase research capabilities 29 April 2026 ICON provides update on audit committee investigation and timing of fourth quarter and full year 2025 financial results Events 3 September 2026 NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) 22 September 2026 - 23 September 2026 Beginners/Intermediate Online NONMEM/PDx-Pop Workshop 24 September 2026 Advanced Online NONMEM/PDx-Pop Workshop 11 October 2026 New and Advanced Features of NONMEM 7.6 at ACoP 2026 In Person Workshop Awards ICON Press office enquiries Videos Media articles What's happening in ICON ICON Plc Latest issue now available. Join thousands of subscribers who have discovered the convenience of our free monthly publication, by signing up today. https://ow.ly/hTYQ50Zu7sT Compiled and collated by ICON’s Regulatory I... 13 Aug View post View webpage ICON Plc The European Health Data Space (EHDS) is set to transform how real-world evidence is generated across Europe. In this article, ICON authors explore how CROs must adapt to a new landscape of secure data access, interoper... 12 Aug View post View webpage ICON Plc As we recognise National Immunisation Awareness Month (#NIAM), it's important to remember that vaccine decisions for rare autoimmune conditions should be made on an individual basis. Discover key elements of a vaccine sc... 12 Aug View post View webpage ICON Plc The second article in MedTech Insight's PPWR series explores one of the most misunderstood concepts in the EU's Packaging and Packaging Waste Regulation: the distinction between a packaging manufacturer and a producer. ... 11 Aug View post View webpage ICON Plc From MS to NMOSD to early Alzheimer's disease, neurologic mAbs are delivering proven clinical benefit. But as efficacy becomes less of a differentiator, what determines whether these therapies reach patients? In this art... 10 Aug View post View webpage ICON Plc Europe is emerging as an attractive route to global market access for Chinese sponsors. Early consideration of EMA requirements can help avoid costly delays and improve approval success. Read the article: https://ow.ly... 7 Aug View post View webpage ICON Plc Every successful clinical trial starts long before the first participant is enrolled. Site Selection and Activation is one of the most important, yet often overlooked, stages of clinical research. From identifying the r... 7 Aug View post View webpage ICON Plc Preparing for Italy's new serialisation framework requires more than regulatory awareness. Marketing authorisation holders, manufacturers and supply chain partners will need to assess packaging configurations, validate ... 6 Aug View post View webpage ICON Plc Regulatory pathways for biosimilars are changing, with reduced clinical requirements placing greater emphasis on analytical comparability and manufacturing excellence. Understanding how to respond to these shifts can mak... 6 Aug View post View webpage ICON Plc As biotech confidence returns and deal activity accelerates, companies have an opportunity to position themselves for the next phase of growth. In a new BioPharma Dive article, Deepali Suri, President of ICON Biotech, s... 5 Aug View post View webpage ICON Plc We are proud to share that ICON has been named a Winner for Organisational Excellence for the second year running at the GCC India Workplace Innovation Summit & Awards 2026. This recognition celebrates organisations red... 5 Aug View post View webpage ICON Plc Vaccines save millions of lives each year and help protect communities from preventable diseases. In support of National Immunisation Awareness Month, ICON is proud to have participated in 147 vaccine studies across key ... 4 Aug View post View webpage
